Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Next-Generation Sequencing in Cardiovascular Disease: Present Clinical Applications and the Horizon of Precision Medicine.

Literature DB >> 28137961

Next-Generation Sequencing in Cardiovascular Disease: Present Clinical Applications and the Horizon of Precision Medicine.

Victoria N Parikh¹, Euan A Ashley².

Abstract

Entities: Chemical Disease Gene Species

Keywords: genetic heart disease; genetic testing; genetics; human

Mesh：

Year: 2017 PMID： 28137961 PMCID： PMC5310819 DOI： 10.1161/CIRCULATIONAHA.116.024258

Source DB: PubMed Journal: Circulation ISSN： 0009-7322 Impact factor: 29.690

× No keyword cloud information.

5 in total

1. Clinical assessment incorporating a personal genome.

Authors: Euan A Ashley; Atul J Butte; Matthew T Wheeler; Rong Chen; Teri E Klein; Frederick E Dewey; Joel T Dudley; Kelly E Ormond; Aleksandra Pavlovic; Alexander A Morgan; Dmitry Pushkarev; Norma F Neff; Louanne Hudgins; Li Gong; Laura M Hodges; Dorit S Berlin; Caroline F Thorn; Katrin Sangkuhl; Joan M Hebert; Mark Woon; Hersh Sagreiya; Ryan Whaley; Joshua W Knowles; Michael F Chou; Joseph V Thakuria; Abraham M Rosenbaum; Alexander Wait Zaranek; George M Church; Henry T Greely; Stephen R Quake; Russ B Altman
Journal: Lancet Date: 2010-05-01 Impact factor: 79.321

Review 2. Genetic testing in cardiovascular medicine: current landscape and future horizons.

Authors: Amy C Sturm; Ray E Hershberger
Journal: Curr Opin Cardiol Date: 2013-05 Impact factor: 2.161

Review 3. Towards precision medicine.

Authors: Euan A Ashley
Journal: Nat Rev Genet Date: 2016-08-16 Impact factor: 53.242

Review 4. Coming of age: ten years of next-generation sequencing technologies.

Authors: Sara Goodwin; John D McPherson; W Richard McCombie
Journal: Nat Rev Genet Date: 2016-05-17 Impact factor: 53.242

5. Molecular findings among patients referred for clinical whole-exome sequencing.

Authors: Yaping Yang; Donna M Muzny; Fan Xia; Zhiyv Niu; Richard Person; Yan Ding; Patricia Ward; Alicia Braxton; Min Wang; Christian Buhay; Narayanan Veeraraghavan; Alicia Hawes; Theodore Chiang; Magalie Leduc; Joke Beuten; Jing Zhang; Weimin He; Jennifer Scull; Alecia Willis; Megan Landsverk; William J Craigen; Mir Reza Bekheirnia; Asbjorg Stray-Pedersen; Pengfei Liu; Shu Wen; Wendy Alcaraz; Hong Cui; Magdalena Walkiewicz; Jeffrey Reid; Matthew Bainbridge; Ankita Patel; Eric Boerwinkle; Arthur L Beaudet; James R Lupski; Sharon E Plon; Richard A Gibbs; Christine M Eng
Journal: JAMA Date: 2014-11-12 Impact factor: 56.272

5 in total

8 in total

Review 7. Application of Single-Nucleotide Polymorphism-Related Risk Estimates in Identification of Increased Genetic Susceptibility to Cardiovascular Diseases: A Literature Review.

Authors: Szilvia Fiatal; Róza Ádány
Journal: Front Public Health Date: 2018-01-31

8. Reevaluating the Mutation Classification in Genetic Studies of Bradycardia Using ACMG/AMP Variant Classification Framework.

Authors: Liting Cheng; Xiaoyan Li; Lin Zhao; Zefeng Wang; Junmeng Zhang; Zhuo Liang; Yongquan Wu
Journal: Int J Genomics Date: 2020-02-25 Impact factor: 2.326

8 in total

Next-Generation Sequencing in Cardiovascular Disease: Present Clinical Applications and the Horizon of Precision Medicine.

1. Clinical assessment incorporating a personal genome.

Review 2. Genetic testing in cardiovascular medicine: current landscape and future horizons.

Review 3. Towards precision medicine.

Review 4. Coming of age: ten years of next-generation sequencing technologies.

5. Molecular findings among patients referred for clinical whole-exome sequencing.

1. The Missing LINC for Genetic Cardiovascular Disease?

Review 2. Genetics of Dilated Cardiomyopathy: Clinical Implications.

Review 3. Recent Advances in Understanding and Managing Cardiomyopathy.

Review 4. Cardiovascular Precision Medicine in the Genomics Era.

5. Molecular Autopsy for Sudden Death in the Young: Is Data Aggregation the Key?

6. Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study.

Review 7. Application of Single-Nucleotide Polymorphism-Related Risk Estimates in Identification of Increased Genetic Susceptibility to Cardiovascular Diseases: A Literature Review.

8. Reevaluating the Mutation Classification in Genetic Studies of Bradycardia Using ACMG/AMP Variant Classification Framework.